Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. [electronic resource]
Producer: 20130228Description: 1979-87 p. digitalISSN:- 1538-7836
- Administration, Oral
- Aged
- Aged, 80 and over
- Anticoagulants -- administration & dosage
- Atrial Fibrillation -- blood
- Benzimidazoles -- administration & dosage
- Clinical Trials, Phase III as Topic
- Dabigatran
- Evidence-Based Medicine
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Morpholines -- administration & dosage
- Patient Safety
- Preventive Health Services
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Randomized Controlled Trials as Topic
- Rivaroxaban
- Stroke -- blood
- Thiophenes -- administration & dosage
- Treatment Outcome
- Warfarin -- administration & dosage
- beta-Alanine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.